20 results
Home-based record (HBR) for Guinea-Bissau circa 2008 (maternal)
Home-based record (HBR) for Guinea-Bissau circa 2010 (TT)
From 24-30 April 2016, countries in the African Region commemorated the 6th African Vaccination Week (AVW).The goal of AVW is to strengthen immunization programmes in the African...
Background
Measles vaccination campaigns targeting children aged 9–59 months are conducted every three years in Guinea-Bissau. Studies have demonstrated beneficial non-specific effects of...
Background
Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
There is now clear evidence that the simplistic conventional model of immunization is invalid [1]. We can no longer assume that a vaccine acts independently of other vaccines, or that it influences...
Vaccines may have non-specific effects. An observational study from Guinea-Bissau suggested that oral polio vaccine at birth (OPV0) provided with Bacillus Calmette–Guérin (BCG) vaccine was...
In 2008, the GAVI Alliance funded the introduction of new vaccines (including pentavalent diphtheria-tetanus-pertussis [DTP] plus hepatitis B and Haemophilus influenzae type b antigens) in...
Studies from low-income countries indicate that co-administration of inactivated diphtheria–tetanus–pertussis (DTP) vaccine and live attenuated measles vaccine (MV) is associated with increased...
The World Health Organization recommends vitamin A supplementation (VAS) at routine vaccination contacts after 6 months of age based on the assumption that it reduces mortality by 24%. The policy has...
BCG vaccination is recommended at birth in low-income countries, but vaccination is often delayed. Often 20-dose vials of BCG are not opened unless at least ten children are present for vaccination...
The WHO Strategic Advisory Group of Experts (SAGE) on immunization recently published their conclusions from a systematic review of the ‘non-specific’ or ‘heterologous effects’ of vaccines,...
The researchers investigated the effect of OPV0 on infant mortality in a randomized trial in Guinea-Bissau. The study concludes that OPV0 may be associated with nonspecific protection against...
Randomised trials have shown that measles vaccine (MV) prevents non-measles deaths. MV-campaigns are conducted to eliminate measles infection.The overall mortality effect of MV-campaigns has not been...
The following report displays data and figures on the introduction status of Hib vaccine, pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV)* both globally...
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA...
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...